ATE216229T1 - Emulsion zur verabreichung eines sphingolipids und deren verwendung - Google Patents

Emulsion zur verabreichung eines sphingolipids und deren verwendung

Info

Publication number
ATE216229T1
ATE216229T1 AT95942970T AT95942970T ATE216229T1 AT E216229 T1 ATE216229 T1 AT E216229T1 AT 95942970 T AT95942970 T AT 95942970T AT 95942970 T AT95942970 T AT 95942970T AT E216229 T1 ATE216229 T1 AT E216229T1
Authority
AT
Austria
Prior art keywords
emulsion
sphingolipid
administration
cholesterol
cationic
Prior art date
Application number
AT95942970T
Other languages
English (en)
Inventor
Robert T Lyons
Original Assignee
Pharmacia & Upjohn Ab
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab, Lilly Co Eli filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE216229T1 publication Critical patent/ATE216229T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95942970T 1994-12-07 1995-12-01 Emulsion zur verabreichung eines sphingolipids und deren verwendung ATE216229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/351,635 US5635536A (en) 1994-12-07 1994-12-07 Emulsion suitable for administering a sphingolipid
PCT/US1995/015687 WO1996017603A1 (en) 1994-12-07 1995-12-01 Emulsion suitable for administering a sphingolipid and use thereof

Publications (1)

Publication Number Publication Date
ATE216229T1 true ATE216229T1 (de) 2002-05-15

Family

ID=23381694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942970T ATE216229T1 (de) 1994-12-07 1995-12-01 Emulsion zur verabreichung eines sphingolipids und deren verwendung

Country Status (10)

Country Link
US (2) US5635536A (de)
EP (1) EP0799035B1 (de)
JP (1) JPH10510267A (de)
AT (1) ATE216229T1 (de)
AU (1) AU4414096A (de)
DE (1) DE69526450T2 (de)
DK (1) DK0799035T3 (de)
ES (1) ES2177676T3 (de)
PT (1) PT799035E (de)
WO (1) WO1996017603A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720184B1 (en) 1991-08-05 2004-04-13 Emory University Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US6982142B2 (en) 1997-12-01 2006-01-03 John Wayne Cancer Institute Methods for screening therapeutically effective agents
DE69943314D1 (de) * 1998-02-12 2011-05-12 Kapil N Bhalla Sphingolipid-derivate und verfahren zu deren verwendung
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
CA2335617C (en) * 1998-06-24 2009-12-15 Novirio Pharmaceuticals Limited Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6368831B1 (en) 1998-06-29 2002-04-09 Childrens Hospital Los Angeles Treatment of hyperproliferative disorders
AU4724599A (en) 1998-06-29 2000-01-17 Children's Hospital Of Los Angeles Treatment of hyperproliferative disorders
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
AU2002354131A1 (en) * 2001-12-10 2003-06-23 Kao Corporation Ceramide emulsions
WO2004075834A2 (en) * 2003-02-21 2004-09-10 Childrens Hospital Los Angeles Research Institute Stabilized pharmaceutical compositions of safingol and methods of using the same
JP2006028109A (ja) * 2004-07-20 2006-02-02 Kao Corp 水中油型乳化組成物
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2011044207A2 (en) * 2009-10-06 2011-04-14 L'oreal S.A. Compositions containing a high concentration of polar sphingolipid(s)
JP6960984B2 (ja) * 2019-12-26 2021-11-05 三菱電機株式会社 電子装置及びその絶縁部材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5198470A (en) * 1989-09-21 1993-03-30 L'oreal Lipid compounds derived from sphingosines, process for preparing these and their applications, in particular in cosmetics and in the pharmacy of skin conditions
FR2652002B1 (fr) * 1989-09-21 1991-11-29 Oreal Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie.
DE4015108A1 (de) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
USH1168H (en) * 1991-08-21 1993-04-06 The United States Of America As Represented By The Secretary Of The Navy Inhibitors of protein kinase C activity as protectors against septic shock and reducers of ARDS

Also Published As

Publication number Publication date
JPH10510267A (ja) 1998-10-06
AU4414096A (en) 1996-06-26
WO1996017603A1 (en) 1996-06-13
DE69526450T2 (de) 2002-11-14
ES2177676T3 (es) 2002-12-16
US5635536A (en) 1997-06-03
EP0799035A1 (de) 1997-10-08
EP0799035A4 (de) 1999-06-09
DE69526450D1 (de) 2002-05-23
DK0799035T3 (da) 2002-07-22
EP0799035B1 (de) 2002-04-17
PT799035E (pt) 2002-09-30
US5677341A (en) 1997-10-14

Similar Documents

Publication Publication Date Title
ATE216229T1 (de) Emulsion zur verabreichung eines sphingolipids und deren verwendung
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
DK1265698T3 (da) Lipidnanokapsler, fremgangsmåde til fremstilling heraf samt anvendelse som medikament
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
BR9510452A (pt) Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos
DK0605203T3 (da) Antiallergisk sammensætning til oftalmisk eller nasal anvendelse
ATE132040T1 (de) Verwendung von phospholipiden zur herstellung eines topischen arzneimittels zur beinflussung des serumcholesterinspiegels
BR9915008A (pt) Composição de xampu, e, processo para preparação da mesma
DE69121561D1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
AR005104A1 (es) Emulsion acuosa estable con un ph no mayor de 7 que comprende un ingrediente liquido hidrofobo y un sistema emulsionante, y proceso para supreparacion.
ATE223205T1 (de) Verfahren zur herstellung von liposomen, die hydrophobische artzneistoffe enthalten
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
BR0211008A (pt) Combinação de ingrediente ativo, uso de uma combinação de ingrediente ativo e método para a terapia farmacológia de uma substância que causa dependência ou que seja intoxicante
ES2060329T3 (es) Emulsion que contiene calcitonina, para administracion nasal.
ATE132758T1 (de) Anwendung von dispersionen von magneto-ionischen partikeln in mri-kontrast-mitteln
AU2940992A (en) Immediate-effect flurbiprofen-containing medicament and its use
DK0647129T3 (da) Præparat til topisk anvendelse
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ES2180632T3 (es) Activador de tiol estable en un liquido.
BR0213434A (pt) Método para evitar demência em um paciente, e, uso de rosuvastatina ou seu sal farmaceuticamente aceitável
BR9713514A (pt) Novo uso de creatina
ATE230251T1 (de) Lipidmembran zusammensetzungen
MX9708399A (es) Gel para afeitar con espumacion diferida que contiene un monoester de acido de 4 a 10 atomos de carbono y alcohol de 16 a 18 atomos de carbono.
MX9801902A (es) Composicion dermatologica antiseptica y procedimiento para su fabricacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee